PROSTATE NEOPLASM
Clinical trials for PROSTATE NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new PROSTATE NEOPLASM trials appear
Sign up with your email to follow new studies for PROSTATE NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New radiation therapy targets Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage study tests a new drug, LY4257496, that delivers radiation directly to cancer cells with a specific protein (GRPR). It is for adults with advanced breast, colorectal, prostate, or endometrial cancer that has spread. The goal is to find a safe dose and see if it s…
Matched conditions: PROSTATE NEOPLASM
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
Can a stronger radiation blast beat prostate cancer without worse side effects?
Disease control Recruiting nowThis study is testing if giving a higher dose of radiation directly to the prostate (called HDR brachytherapy) can better control early-stage prostate cancer without causing more side effects. About 36 men with low- or favorable intermediate-risk prostate cancer will receive one …
Matched conditions: PROSTATE NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
New MRI tool could sharpen prostate cancer detection
Diagnosis Recruiting nowThis study is testing a new computer software that creates risk maps from MRI scans to help doctors decide if a prostate biopsy is needed. About 180 people with known or suspected prostate cancer will have one MRI and one or two biopsies, and be followed for a year. The goal is t…
Matched conditions: PROSTATE NEOPLASM
Phase: NA • Sponsor: University of Chicago • Aim: Diagnosis
Last updated May 22, 2026 13:51 UTC
-
New hope for Men's hot flashes: drug targets sweaty side effect of prostate cancer treatment
Symptom relief Recruiting nowThis study tests a drug called fezolinetant to see if it can reduce hot flashes in men with prostate cancer who are on hormone therapy (ADT). About 60 men will take either the drug or a placebo daily for 4 weeks. Researchers will track hot flash frequency, severity, and any liver…
Matched conditions: PROSTATE NEOPLASM
Phase: PHASE2 • Sponsor: Shehzad Basaria, M.D. • Aim: Symptom relief
Last updated May 26, 2026 07:32 UTC
-
Mayo clinic tests sharper MRI for prostate cancer detection
Knowledge-focused Recruiting nowThis study aims to improve MRI scans for prostate cancer by testing new image-reconstruction methods. Researchers will compare standard and experimental algorithms to see which produces clearer images. About 1000 adults will participate, and no treatment or medication is involved…
Matched conditions: PROSTATE NEOPLASM
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 26, 2026 07:37 UTC
-
8,000-Patient study aims to sharpen cancer radiation with Real-Time MRI
Knowledge-focused Recruiting nowThis study is a large registry that will follow 8,000 cancer patients who receive radiation therapy guided by an MR-Linac, a machine that combines an MRI scanner with a radiation beam. The goal is to see if this technology helps people live longer, controls tumors better, and imp…
Matched conditions: PROSTATE NEOPLASM
Sponsor: UMC Utrecht • Aim: Knowledge-focused
Last updated May 20, 2026 11:55 UTC